AKR1C3-IN-9 |
| Katalog-Nr.GC68633 |
AKR1C3-IN-9 ist ein selektiver Inhibitor der Aldehyd-Keton-Reduktase 1C3 (AKR1C3) mit einer IC50 von 8,92 nM. AKR1C3-IN-9 kehrt signifikant die Doxorubicin (DOX)-Resistenz in resistenten Brustkrebszelllinien um.
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for AKR1C3-IN-9
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for AKR1C3-IN-9
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *